Back to Journals » Drug Design, Development and Therapy » Volume 3

Review

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty

       
Total article views   HTML views PDF downloads Totals
8,451 Dovepress* 8,451+ 2,711 11,162
Totals 8,451 2,711 11,162
*Since 23 December 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
16 0 0 0 8 8

View citations on Google Scholar